These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11036836)

  • 1. Fas and Fas ligand gene polymorphisms in primary Sjögren's syndrome.
    Bolstad AI; Wargelius A; Nakken B; Haga HJ; Jonsson R
    J Rheumatol; 2000 Oct; 27(10):2397-405. PubMed ID: 11036836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of IL-1 beta gene in Japanese patients with Sjögren's syndrome and systemic lupus erythematosus.
    Muraki Y; Tsutsumi A; Takahashi R; Suzuki E; Hayashi T; Chino Y; Goto D; Matsumoto I; Murata H; Noguchi E; Sumida T
    J Rheumatol; 2004 Apr; 31(4):720-5. PubMed ID: 15088297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of CTLA4 haplotypes on susceptibility and some extraglandular manifestations in primary Sjögren's syndrome.
    Downie-Doyle S; Bayat N; Rischmueller M; Lester S
    Arthritis Rheum; 2006 Aug; 54(8):2434-40. PubMed ID: 16869018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas gene polymorphisms in systemic lupus erythematosus and serum levels of some apoptosis-related molecules.
    Arasteh JM; Sarvestani EK; Aflaki E; Amirghofran Z
    Immunol Invest; 2010; 39(1):27-38. PubMed ID: 20064083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of Fas (CD95) and FasL (CD178) polymorphisms in liver transplant recipients.
    Marín LA; Muro M; Moya-Quiles MR; Miras M; Minguela A; Bermejo J; Sanchez-Bueno F; Parrilla P; Alvarez-López MR
    Tissue Antigens; 2006 Feb; 67(2):117-26. PubMed ID: 16441482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased salivary gland tissue expression of Fas, Fas ligand, cytotoxic T lymphocyte-associated antigen 4, and programmed cell death 1 in primary Sjögren's syndrome.
    Bolstad AI; Eiken HG; Rosenlund B; Alarcón-Riquelme ME; Jonsson R
    Arthritis Rheum; 2003 Jan; 48(1):174-85. PubMed ID: 12528117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants of chemokine receptor CCR7 in patients with systemic lupus erythematosus, Sjogren's syndrome and systemic sclerosis.
    Kahlmann D; Davalos-Misslitz AC; Ohl L; Stanke F; Witte T; Förster R
    BMC Genet; 2007 Jun; 8():33. PubMed ID: 17587445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in promoter region of FAS and FASL gene and risk of cardia gastric adenocarcinoma.
    Zhou RM; Wang N; Chen ZF; Duan YN; Sun DL; Li Y
    J Gastroenterol Hepatol; 2010 Mar; 25(3):555-61. PubMed ID: 20074157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of Fas-ligand mRNA in Sjögren's syndrome patients with enlarged exocrine glands.
    Tsuzaka K; Matsumoto Y; Sasaki Y; Abe T; Tsubota K; Takeuchi T
    Autoimmunity; 2007 Nov; 40(7):497-502. PubMed ID: 17966039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus.
    Kanemitsu S; Ihara K; Saifddin A; Otsuka T; Takeuchi T; Nagayama J; Kuwano M; Hara T
    J Rheumatol; 2002 Jun; 29(6):1183-8. PubMed ID: 12064832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjögren's syndrome.
    Hulkkonen J; Pertovaara M; Antonen J; Lahdenpohja N; Pasternack A; Hurme M
    Arthritis Rheum; 2001 Jan; 44(1):176-9. PubMed ID: 11212157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjögren's syndrome.
    Gottenberg JE; Busson M; Loiseau P; Dourche M; Cohen-Solal J; Lepage V; Charron D; Miceli C; Sibilia J; Mariette X
    Arthritis Rheum; 2004 Feb; 50(2):570-80. PubMed ID: 14872501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas polymorphisms influence susceptibility to autoimmune hepatitis.
    Hiraide A; Imazeki F; Yokosuka O; Kanda T; Kojima H; Fukai K; Suzuki Y; Hata A; Saisho H
    Am J Gastroenterol; 2005 Jun; 100(6):1322-9. PubMed ID: 15929764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of Fas and Fas-L mutations in patients with lymphoproliferative disorders associated with Sjögren's syndrome and type II mixed cryoglobulinemia.
    Bertolo F; De Vita S; Dolcetti R; Carbone A; Ferraccioli GF; Bartoli E; Boiocchi M
    Clin Exp Rheumatol; 1999; 17(3):339-42. PubMed ID: 10410268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of STAT4 polymorphism in primary Sjögren's syndrome.
    Palomino-Morales RJ; Diaz-Gallo LM; Witte T; Anaya JM; Martín J
    J Rheumatol; 2010 May; 37(5):1016-9. PubMed ID: 20360187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of interleukin-10 promoter polymorphisms in primary Sjogren's syndrome.
    Willeke P; Gaubitz M; Schotte H; Becker H; Domschke W; Schlüter B
    Scand J Rheumatol; 2008; 37(4):293-9. PubMed ID: 18612930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in the apoptosis-associated genes FAS and FASL and risk of oral cancer and malignant potential of oral premalignant lesions in a Taiwanese population.
    Wang LH; Ting SC; Chen CH; Tsai CC; Lung O; Liu TC; Lee CW; Wang YY; Tsai CL; Lin YC
    J Oral Pathol Med; 2010 Feb; 39(2):155-61. PubMed ID: 20359312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of salivary gland epithelial cell injury in Sjogren's syndrome: in vitro assessment of T cell-derived cytokines and Fas protein expression.
    Abu-Helu RF; Dimitriou ID; Kapsogeorgou EK; Moutsopoulos HM; Manoussakis MN
    J Autoimmun; 2001 Sep; 17(2):141-53. PubMed ID: 11591123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of fas ligand gene mutation in patients with systemic lupus erythematosus.
    Kojima T; Horiuchi T; Nishizaka H; Sawabe T; Higuchi M; Harashima SI; Yoshizawa S; Tsukamoto H; Nagasawa K; Niho Y
    Arthritis Rheum; 2000 Jan; 43(1):135-9. PubMed ID: 10643709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations.
    Korkolopoulou P; Goudopoulou A; Voutsinas G; Thomas-Tsagli E; Kapralos P; Patsouris E; Saetta AA
    Urology; 2004 Jun; 63(6):1198-204. PubMed ID: 15183989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.